The AST/ALT (De Ritis) ratio as a significant prognostic factor in myelodysplastic syndrome

Ying Chena Laboratory of Stem Cell Transplantation, The First Affiliated Hospital of Ningbo University, Ningbo, People’s Republic of China;b Ningbo Clinical Research Center For Hematologic Malignancies, Ningbo, People’s Republic of ChinaView further author information

Yue Wua Laboratory of Stem Cell Transplantation, The First Affiliated Hospital of Ningbo University, Ningbo, People’s Republic of China;c Medical School, Ningbo University, Ningbo, People’s Republic of ChinaView further author information

Ting Chenc Medical School, Ningbo University, Ningbo, People’s Republic of China;d Hematology Department, The First Affiliated Hospital of Ningbo University, Ningbo, People’s Republic of ChinaView further author information

Duobing Zoua Laboratory of Stem Cell Transplantation, The First Affiliated Hospital of Ningbo University, Ningbo, People’s Republic of China;b Ningbo Clinical Research Center For Hematologic Malignancies, Ningbo, People’s Republic of ChinaView further author information

Cong Shia Laboratory of Stem Cell Transplantation, The First Affiliated Hospital of Ningbo University, Ningbo, People’s Republic of China;b Ningbo Clinical Research Center For Hematologic Malignancies, Ningbo, People’s Republic of ChinaView further author information

Ningning Wua Laboratory of Stem Cell Transplantation, The First Affiliated Hospital of Ningbo University, Ningbo, People’s Republic of China;b Ningbo Clinical Research Center For Hematologic Malignancies, Ningbo, People’s Republic of ChinaView further author information

Lixia Shengb Ningbo Clinical Research Center For Hematologic Malignancies, Ningbo, People’s Republic of China;d Hematology Department, The First Affiliated Hospital of Ningbo University, Ningbo, People’s Republic of ChinaView further author information

Guifang Ouyangb Ningbo Clinical Research Center For Hematologic Malignancies, Ningbo, People’s Republic of China;d Hematology Department, The First Affiliated Hospital of Ningbo University, Ningbo, People’s Republic of ChinaCorrespondence[email protected]
View further author information

Qitian Mua Laboratory of Stem Cell Transplantation, The First Affiliated Hospital of Ningbo University, Ningbo, People’s Republic of China;b Ningbo Clinical Research Center For Hematologic Malignancies, Ningbo, People’s Republic of ChinaCorrespondence[email protected]
View further author information

show all

The AST/ALT (De Ritis) ratio as a significant prognostic factor in myelodysplastic syndrome

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The AST/ALT (De Ritis) ratio as a significant prognostic factor in myelodysplastic syndrome

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date